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Activation of c-myc gene mediates the mitogenic effects of
oxalate in LLC-PK1 cells, a line of renal epithelial cells
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Activation of c-myc gene mediates the mitogenic effects of oxalate in
LLC-PK1 cells, a line of renal epithelial cells. Recent studies on LLC-PK1
cells demonstrated that oxalate, a simple dicarhoxylic acid, acts as a
mitogen for these renal epithelial cells. Exposure to oxalate initiates DNA
synthesis, induces the expression of one of the early growth response genes
c-myc and stimulates proliferation of quiescent cultures of LLC-PK1 cells.
The present studies examined the possibility that expression of the c-myc
prot000cogene is obligatory for this mitogenic response. Specifically we
determined whether pretreatment with c-myc antisense oligonuclcotidcs
would block the proliferative effects of oxalate in LLC-PK1 cells. Quies-
cent cultures of LLC-PK cells were exposed to oxalate in the presence
and absence of c-myc antisense and the effects of oxalate on c-myc protein
expression (Myc), DNA synthesis and cell growth were assessed. Exposure
of cells to oxalate alone increased the expression of Myc within two hours.
Pretreatment with c-myc antiseose abolished this response. Further,
pretreatment of cells with c-myc antisense but not nonsense oligonucleo-
tides blocked the oxalate-induced initiation of DNA synthesis. Increases in
cell number in response to oxalate (measured after 72 hr exposure) were
also blocked by exposure to c-myc antisense. These findings suggest that
c-myc gene expression is critical for the mitogenic effects of oxalate in
LLC-PK1 cells.
Oxalate, an organic dicarboxylate, is an end product of metab-
olism that is excreted primarily by the kidney. Renal excretion of
oxalate is mediated by a variety of transport systems at the apical
and basolateral membrane of epithelial cells [1—3]; and during the
transcellular oxalate flux, oxalate accumulates intracellularly
within these cells [3, 4]. The most common pathological condition
involving oxalate is nephrolithiasis (formation of calcium oxalate
stones in the kidney). Deposits of oxalate also occur commonly in
end-stage renal disease due to retention of oxalate [5, 6]. In
addition, oxalate deposits have been observed at sites of tissue
damage and in several pathological conditions characterized by
aberrent proliferation such as thyroid hyperplasia [71, acquired
renal cystic disease [81 and benign breast lesions [9, 10].
The association of oxalate deposits with aberrant cell growth is
of particular interest given our recent findings that oxalate
produces marked effects on the growth and viability of LLC-PK1
cells, a line of renal epithelial cells. Recent studies demonstrated
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that exposure of LLC-PK1 cells to oxalate increases 3H thymidine
incorporation into DNA and produces biphasic effects on cell
number, promoting a net increase in cell numbers at lower oxalatc
concentratons (< 350 j.LM free oxalate) and a net cell loss at higher
concentrations (> 350 /.LM) [11]. These findings provide evidence
that oxalate can no longer be considered an inert end product of
metabolism. Rather these and other studies demonstrate that
oxalate interactions with renal epithelial cells elicit a programmed
sequence of events that can lead to cell proliferation [11, 12] or
cell death [11, 13—16].
Increased expression of the c-myc oncogene was one of the
early events in mitogenic response to oxalate exposure [11]. The
present studies investigated the possibility that the oxalate-in-
duced increase in c-myc gene expression might be obligatory for
this proliferative response. To this end we determined whether
pretreatment with c-myc antisense oligonucleotides would block
the proliferative effects of oxalate in LLC-PK1 cells. The results
from these studies support this possibility and suggest that c-myc
gene expression is critical for the mitogenic effects of oxalate.
Methods
Materials
Dulbecco-Vogt modified Eagle's medium (DMEM), penicillin!
streptomycin, calf serum, dithiothreitol, and T4 polynucleotide
kinase were obtained from GIBCO BRL (Long Island, NY,
USA). Sephadex G25 columns were obtained from Pharmacia
LKB Biotechnology Inc. (Piscataway, NJ, USA), while Biotrans
nylon transfer membranes were purchased from ICN (Irvine, CA,
USA). 3H-thymidine was obtained from New England Nuclear
(Cambridge, MA, USA) while 32P was obtained from Amersham
(Arlington Heights, IL, USA). The phosphorothioate-derivatized
antisense oligonucleotides directed against human c-myc (target-
ed to the translational start sequence: GAA GTT CAC GTT
GAG GGG CAT) as well as a nonsense oligonucleotide contain-
ing the same bases in random order were synthesized by the
Nucleic Acid Core at the University of Massachusetts Medical
School. The mouse monoclonal antibody to human Myc, as well as
the oligonucleotide probe for human c-myc mRNA were obtained
from Oncogene Science Inc (Uniondale, NY, USA). Other chem-
icals used in this study were obtained from Sigma Chemical Co
(St. Louis, MO, USA).
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Cell culture
LLC-PK1 cells, a renal epithelial cell line of porcine origin,
were obtained from the American Type Culture Collection (Be-
thesda, MD, USA) and used between passages 216 to 240. The
cells were maintained in an atmosphere of 5% C02195% air in a
humidified 37°C incubator and serially passaged in Dulbecco-
Vogt modified Eagle's medium (DMEM), supplemented with
10% fetal bovine serum, penicillin (100 U/ml), streptomycin (100
g/ml) and glucose (4.5 g/liter). Where indicated, sodium oxalate
was added at a concentration of 0.2 to 4.0 m total oxalate, values
that correspond to 0.07—1.6 m free oxalate (due to complexation
with calcium and other ions). Free oxalate concentrations in the
buffers employed here were calculated using the EQUIL II
program [17]. These oxalate concentrations are somewhat higher
than might be expected to occur normally in proximal tubular
fluid since oxalate concentrations in the initial filtrate are 5 to 10
LM. However, oxalate undergoes net secretion in the proximal
tubule [181 and oxalate is concentrated approximately fourfold by
renal tubular cells [41. Therefore, the actual oxalate concentra-
tions experienced by proximal tubular cells in vivo may approach
those employed here.
3H-thymidine incorporation
LLC-PK1 cells were subcultured at a high plating density in
six-well plates and grown to confluence. Forty-eight hours after
the last medium change, cells were incubated in serum-free
DMEM for 12 to 18 hours. These quiescent cells were then
preincubated for one hour in DMEM (0.25% serum) containing
varying amounts of antisense (10, 50 or 100 jig) or nonsense (100
jig) oligonucleotides and incubated for 18 hours in the same
medium supplemented with oxalate (350 jiM). Control cultures
were exposed to DMEM containing either 0.25 or 10% calf serum
during this interval. After this incubation period, cultures received
2 to 5 jiCi of 3H-thymidine per well and were allowed to
incorporate label for six hours. The culture medium was then
removed, the cell cultures were rinsed twice with PBS, pH 7.4, and
trypsinized for 30 to 45 minutes at 37°C. Two milliters of cell
suspension were combined with 2 ml of 10% trichioroacetic acid
and the acid insoluble material was collected on Whatman glass
fiber filters. The filters were air dried and counted in 10 ml of
Optifluor scintillation fluid.
To establish that the oxalate-induced increase in 3H-thymidine
incorporation into acid-precipitable material indeed reflected
increased DNA synthesis, additional studies examined the distri-
bution of labeled thymidine in autoradiograms from treated and
untreated cells. For such studies, log phase cultures of LLC-PK
cells were growth arrested by serum starvation for 48 hours. Cells
were then incubated for 8 to 24 hours in culture medium
containing 0 or 350 jiM free oxalate plus 0.25 or 10% fetal calf
serum. Cells were then labeled with 3H thymidine (2.5 to 5
jiCi/mi) for one hour. The medium was then removed, cells were
washed x2 with PBS and fixed in methanol:acetic acid (2:1, 2
mi/well) for 15 to 30 minutes. Cells were washed with methanol
(x2) and air dried. Emulsion (Kodak P-64 autoradiographic
emulsion, pre-warmed to 42°C) was added to each well in the dark
and plates were developed four to five days later. Cells were
counterstained with Geimsa for 10 to 15 minutes and the number
of labeled and unlabeled nuclei was assessed.
Assessment of cell numbers
LLC-PK1 cells were subcultured in 96 well plates and grown to
50 to 75% confluence. Cells were serum starved for at least three
to four hours prior to the addition of fresh medium (DMEM
supplemented with 0.25% serum) with or without c-myc antisense
or nonsense probes (40 jig/ml). Ninety minutes after the addition
of antisense or nonsense probes, varying concentrations of oxalate
(0 to 750 jiM free oxalate) were added and cells were returned to
the incubator for 72 hours. Cells were then washed in PBS and cell
density was determined using crystal violet as described previously
[111. Briefly cells were stained for five minutes (5% crystal violet
in 95% ethanol containing 4% paraformaldehyde), rinsed with
distilled water and air dried. The dye was subsequently extracted
with ethylene glycol monethyl ether and dye absorbance at 570 nm
(0D570) was determined using a Titer Tek multiscan spectropho-
tometer [19]. Separate studies confirmed that dye absorbance was
proportional to cell density in these cultures.
Northern blot analysis
To confirm that the c-myc antisense interacts specifically with
c-myc, mRNA samples from treated cells were analyzed by
Northern analysis as described previously [111. Two probes were
used, a commercially available 40 mer probe for c-myc (Oncogene
Sciences) and the phosphorothioate antisense probe for c-myc
end-labeled with 32P-ATP. Messenger RNA was isolated from
LLC-PK1 cells using an In vitrogen Fast Track mRNA isolation
procedure as described by the manufacturer. The mRNA was
fractionated on an agarose/formaldehyde gel, transferred to a
nylon membrane and heat fixed at 80°C for two hours under
vacuum. The membrane was incubated with hybridization buffer
(1.0 M NaCI, 50 mrvt Tris-HCI, pH 7.5, 10% dextran sulfate, 1%
SDS and 100 jig/mI denatured monologus salmon sperm DNA)
for one hour at 65°C. The membrane was then incubated over-
night at 65°C with either the 40 mer c-myc oligonucleotide probe
or the phosphorothioate c-myc antisense probe (2.5 x 106 cpm).
Unbound radioactivity was removed by sequential washing. The
membrane was then blotted and exposed to X-OMAT AR film in
a Dupont Cornex intensifying screen cassette at —80°C. The film
was developed to visualize bands.
Myc protein expression
Western blot analysis was employed to assess the time course of
oxalate-induced changes in Myc protein expression and the effects
of the c-myc antisense oligonucleotide probe on this expression.
For such studies, confluent cultures of LLC-PK1 cells were serum
starved overnight and treated for predetermined periods (2, 4 or
6 hr) with 350 jiM free oxalate alone or in combination with
antisense oligonucleotides (where indicated, probe was added at a
concentration of 40 jig/ml, 90 minutes prior to oxalate addition).
Cells were then lysed in SDS solubilization buffer and centrifuged.
The supernatants were analyzed for protein content using a Pierce
BCA assay and equal amounts (60 jig) of protein from each
sample were fractionated on a 10% SDS polyacrylamide gel.
Proteins were transferred to Immobilon filters overnight (100
mA) and incubated with blocking buffer [5% nonfat milk in
Tris-buffered saline-Tween buffer (TBST}]. The filters were then
incubated for 90 minutes at room temperature with a mouse
monoclonal antibody to human Myc, washed 3 X with TBST and
incubated for an additional 30 minutes with a rabbit anti-mouse
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antibody conjugated to alkaline phosphatase. After three addi-
tional washes with TBST, alkaline phosphate activity was detected
as recommended by the manufacturer (Oncogene Sci).
Statistical analysis
3H thymidine data from the various treatment groups were
normalized relative to control for each plating and analyzed using
multiple t-tests after applying Bonferroni corrections. For analysis
of cell density data, the crystal violet staining in each sample was
normalized relative to control for that experiment and converted
to a natural logarithm (to normalize distribution). Data from all
experiments were then poolcd and analyzed using a multiple
ANOVA for mixed model (BMDP 3V). Comparisons were made
following Bonferroni adjustment for multiple pairwise compari-
sons.
Results
Effect of phosphorothioate anlisense c-myc oligonucleotides on
oxalate induced c-myc expression
The first series of studies assessed the effects of c-myc antisense
oligonucleotides on the expression of Myc protein in confluent,
growth-arrested cultures of LLC-PK1 cells treated with oxalate.
For these studies, cells were treated with 350 jIM free oxalate for
two, four or six hours either in the presence or absence of
antisense oligonucleotides and Myc protein expression was as-
sessed using Western blot analysis (Fig. 1). Oxalate treatment led
to a time-dependent increase in the expression of a protein that
crossreacts with an antibody to human Myc (lanes B, C and D).
(Note that our previous studies demonstrated maximal oxalate-
induced increase in mRNA expression after 2 hr, [11]). Pretreat-
ment of cells with 40 jIg/mI antisense oligonucleotide to c-myc
(lanes E, F and G) blocked the expression of this protein at all
time points tested.
Treatment
Labeling index
8 hr 17 hr 24 hr
Untreated 6.3 0.9 12.9 1.1 2.6 0.4
Oxalate 350 p.Mfree 44.0 4.7 50.4 5.1 66.8 4.4
10% Calf serum 40.4 6.6 37.7 1.8 ND
Effects of phosphorothioate antisense c-myc oligonucleotides on
oxalate-induced initiation of the DNA synthesis
Previous studies had indicated that oxalate exposure increased
the incorporation of 3H thymidine into TCA-precipitable mate-
rial. Studies carried out in this series of experiments confirmed
this observation and demonstrated that the increase in labeling
indeed reflected incorporation into DNA. As shown in Table 1,
oxalate exposure markedly increased nuclear labeling, that is,
there was an increase in the number of cultured cells which
incorporated 3H thymidine into nuclear DNA. The next series of
studies examined the effect of varying concentrations of c-myc
antisense on oxalate-induced initiation of DNA synthesis. For
these studies, serum-starved, growth-arrested, confluent cultures
of LLC-PK1 cells were exposed to oxalate (350 jIM free) for 24
hours in the presence or absence of c-myc antisense (5 to 100
j.tg/ml) and 3H-thymidine incorporation into a TCA precipitable
material was assessed. The results from a representative experi-
ment, presented in Figure 2, indicated that c-inyc antisense
inhibited the oxalate-induced increase in DNA synthesis at all the
concentrations of antisense tested, with increasing concentrations
of antisense producing greater inhibition. At an antisense concen-
tration of 5 jig/mI, DNA synthesis was inhibited by —60%, while
at an antisense concentration of 35 jxg/ml, DNA synthesis was
inhibited by —98%. A similar pattern was observed in one
additional experiment. At the highest concentrations of c-myc
antisense tested (100 jig/ml), basal DNA synthesis was also
reduced. Nonsense oligonucleotides had no effect on DNA syn-
thesis.
Since preliminary studies suggested that 40 jig/mI of c-myc
antisense was sufficient to fully inhibit oxalate-induced initiation
of DNA synthesis, subsequent studies utilized this concentration
of c-myc antisense. 3H-thymidine incorporation was studied in
serum-starved, growth-arrested, quiescent cultures of LLC-PK1
cells, and the effect of oxalate on DNA synthesis was assessed.
The results from four experiments with triplicate measurements in
each experiment are shown in Figure 3. Note that oxalate
treatment resulted in the reinitiation of DNA synthesis and
treatment with c-myc antisense (but not nonsense) abolished this
effect.
B C D E F G Table 1. Effect of oxalate on nuclear 3H thymidine labeling in
LLC-PK1 cells
Log phase cultures of LLC-PK1 cells were growth arrested by serum
starvation for 48 hr. Cells were then incubated for 7 to 23 hr in complete
culture medium containing 0.25% or 10% serum alone or in combination
with 350 jiM oxalate and pulsed with 3H thymidine for 1 hr. Cells were
washed, fixed, air dried and overlaid with photographic emulsion. The
emulsion was developed 4 days later and the number of cells with reduced
silver grains over the nuclei was assessed for each experimental condition.
The extent of nuclear labeling, that is, the labeling index, is defined as the
number of labeled nuclei/total number of nuclei per field >< 100. Data
reflect means SD from 4—7 independent measurements. ND = not done.
Fig. 1. Western blot analysis of Myc protein expression in LLC-PK, cells.
Proteins were extracted from growth arrested cells treated with oxalate
(350 jIM) c-myc antisense oligonucleotides (40 jig/mI) for 2, 4 or 6
hours. As can be seen from this blot, c-Myc protein is overexpressed in
cells treated with oxalate and pretreatment of these cells with antisense
oligonueleotides to c-myc mRNA abolished the overexpression of Myc.
Lanes B, C and D are extracts from cells treated with oxalate alone for 2,
4 and 6 hours, respectively. Lanes E, F and G are extracts from cells
pretreated (45 mm) with antisense oligonucleotides prior to exposure to
oxalate for 2, 4 and 6 hours, respectively.
120
- 100
8060
o 40
U,
0,
, 20
-c
>,
II!
C-myc antisense, jig/mi
Fig. 2. Effect of vatying concentrations of c-myc antisense on oxalate
induced initiation of DNA synthesis in LLC-PK1 cells. Serum-starved,
growth-arrested confluent monolayers of LLC-PK1 cells were exposed to
oxalate (350 /.LM free) alone or in combination with various concentrations
of antisense c-myc oligonucleotides (5 to 100 pg/ml) for 24 hours. At the
end of the 24 hour period 3H-thymidine incorporation into TCA-precip-
itable material was assessed. Antisense to c-myc inhibited oxalate induced
initiation of DNA synthesis in a dose dependent manner.
Control (0.25% serum) 0.35 mivi oxalate
Fig. 3. Effect of c-myc antisense on DNA synthesis in LLC-PK1 cells.
LLC-PK1 cells were incubated for 18 hours in low serum medium (0.25%
serum) containing oxalate (0 or 350 j.LM) c-myc antisense (40 jg/ml) or
nonsense (100 j.gIml) oligonucleotides. Cultures were then pulsed with
3H-thymidine for another six hours, and the amount of label incorporated
into DNA was assessed. Antisense to c-myc blocked both the oxalate-
induced and the serum-induced increase in 3H-thymidine incorporation.
Nonsense oligonucleotides had no effect. Data are means se from 6 to
12 determinations in 3 separate cell platings. Symbols are: (U) control; ()
antisense; () nonsense. < 0.05 relative to 0.25% serum, ***p < 0.001
relative to 0.25% serum, + +P < 0.01 relative to 0.35 mM oxalate.
Binding of phosphorothioate antisense c-mye oligonucleotides
to RNA
To confirm that the c-myc phosphorothioate oligonucleotide
interacts specifically with c-myc message, we performed a North-
ern analysis using 32P-labeled antisense to c-myc and a commer-
cially available c-myc probe. mRNA was isolated from LLC-PK1
cells, fractionated on agarose gels and transferred to nylon
Fig. 4. Northern blot analysis of c-myc mRNA in LLC-PK1 cells. mRNA
was isolated from cells stimulated with serum, and loaded onto an agarose
gel with equal amounts of RNA loaded in lanes I and TI. The RNA was
then fractionated electrophoretically and transferred to a nitrocellulose
filter. The filter was then was cut into two pieces with lane I on one piece
and lane II on the other. The filter portion containing lane I was probed
with our phosphorothioate c-myc antisense oligonucleotide, while the
portion containing lane II was probed with a commercial probe for human
c-myc. Comparison of the two filter segments in this figure, suggests that
both probes interacted with the same mRNA species.
number
To determine whether or not c-myc expression is required for
the oxalate-induced increase in cell number (which is observed at
low concentrations of oxalate [111), we examined cell numbers
after three days exposure to oxalate alone or in combination with
c-myc antisense. For these studies subconfluent cultures of LLC-
PK cells (50 to 75% confluence) were serum starved for three to
four hours, preincubated for two to three hours with 40 xg/ml of
c-myc antisense and exposed to oxalate (0 to 1.6 m free) for 72
hours. Cell numbers were then assessed as described in the
methods section. The results from these studies (Fig. 5) confirmed
our previous finding that long term exposure (72 hr) to low
concentrations of oxalate significantly increases cell numbers [11]
(P < 0.0001 for 0.16 mi oxalate vs. untreated controls), whereas
exposure to higher concentrations of oxalate either has no net
effect on cell numbers (0.4 mM) or produces a significant cell loss
(0.8 mivi, P < 0.0002 relative to untreated controls). Pretreatment
with c-myc antisense completely blocked the increase in cell
density in response to 0.16 m free oxalate. Antisense treatment
also blocked the response to 10% serum. Note however that
antisense treatment failed to block cell loss in response to high
levels of oxalate ( 800 /.LM free oxalate). Data reflect results from
nine experiments with five replicates in each experiment.
Discussion
The present studies confirmed our previous finding that oxalate
exposure induces c-myc gene expression, increases DNA synthesis
and (at low concentrations) increases cell number in LLC-PK1
cells. The increase in c-myc gene expression was observed within
one hour, with maximal expression observed two hours after
exposure to oxalatc. More importantly, the present studies sug-
gested a causal link between the oxalate-induced increase in c-myc
gene expression and oxalate-induced increase in cellular prolifer-
ation. Specifically, these studies demonstrated that pretreatment
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membranes. Northern blot analysis was carried out using 32P
labeled probes (5' end labeling). Results presented in Figure 4
demonstrate that c-myc antisense oligonucleotides bind to a single
species of RNA. Parallel experiments with commercially available
eDNA probe for c-myc confirmed that both probes were interact-
ing with a single species of mRNA (Fig. 4).
Effect of c-myc antisense on oxalate-induced changes in cell
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Fig. 5. Effect of c-myc antisense on oxalate-
induced proliferation of LLC-PK, cells.
Subconfiuent cultures were incubated for 72
hours with varying concentrations of oxalate in
the presence () and absence (U) of c-myc
antisense (40 J.Lg/ml). Cell numbers were
quantitated using crystal violet. Notc that
oxalate treatment induccd bi-phasic effects on
cell number, producing a significant increase in
cell numbers at a concentration of 0.140 mM,
and a significant loss of cells at 0.70 mM.
Treatment with c-myc antisense blocked the
mitogenic effects but not the toxic effects of
observed at higher doses of oxalate.
with an antisense oligonucleotide directed against c-myc mRNA
blocked the proliferative effects of oxalate.
Antisense oligonucleotides have been used successfully to in-
hibit the expression of a number of gene products, including the
c-myc oncogene [201. Such studies have greatly increased our
understanding as to the cellular functions of these gene products,
and in the case of c-myc, have provided compelling evidence that
this oncogene plays a critical role in cellular proliferation. For
example treatment of hematopoietic cells with c-myc antisense
blocked the progression of these cells from the G to S phase of the
cell cycle and prevented cellular proliferation [20—22]. Similarly,
treatment of human breast cancer cells [23] and vascular smooth
muscle cells [24, 25] with c-myc antisense inhibited cell growth.
Antisense oligonucleotides were also successful in blocking
oxalate actions in LLC-PK1 cells. Pretreatment with c-myc anti-
sense (40 Jkg/ml) blocked the expression of Myc protein. More-
over, pretreatment with c-myc antisense (but not the nonsense
oligonueleotide) inhibited oxalate-induced increase in 3H thymi-
dine incorporation in LLC-PK1 cells. These data indicated that
c-myc expression is required for oxalate-induced initiation of
DNA synthesis in these renal epithelial cells.
Treatment with c-myc antisense also blocked the oxalate-
induced increase in cell number in LLC-PK1 cultures. The success
of these studies was greatly facilitated by the availability of
phosphorothioate derivatized oligonucleotides since these mole-
cules are considerably more stable than conventional nucleotides
[26]. With such probes it was possible to evaluate the long term
effects on cell number (measured after 72 hr) after a single
treatment with moderate doses (40 j.tg/ml) of c-myc antisense.
The specificity of antisense oligonucleotides was recently
brought into question by the studies of Burgess et al, who
suggested that antisense may interact nonspecifically [27]. How-
ever, the results of present studies argue for selectivity of c-myc
antisense. These studies demonstrated that the antisense probe
interacted with the same species of mRNA that is labeled by a
commercially available probe for c-myc, a finding consistent with
several recent in vivo and in vitro studies showing specific inter-
action of c-myc antisense with c-myc mRNA [28, 29].
The precise manner by which oxalate exposure results in
transcriptional activation of c-myc gene remains unclear. The
significance of these findings for renal physiology and pathophys-
iology will also require additional study. There has been one
report of renal hyperplasia in a kidney transplanted into a patient
with hyperoxaluria [30]. In addition, deposits of calcium oxalate
crystals have been noted in a number of conditions characterized
by aberrant proliferation including thyroid hyperplasia [7], ac-
quired renal cystic disease [81 and benign breast lesions [9, 10].
These obervations suggest that the proliferative effects of oxalate
seen in vitro in cultured renal epithelial cells may also occur in
vivo.
In any event, the present studies demonstrated that c-myc gene
expression is one of the critical events in the oxalate-induced
stimulation of DNA synthesis and growth of LLC-PK1 cells.
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